QMI Webinar - Commercialisation of the UK Life Science Technology in China

9 February 2021

The explosion of China’s venture capital activities, the rapid growth from generic to home grown pharmaceuticals and the standardisation to global norms of regulation have made China an ever-attractive market to the UK life science innovation base. The seminar informs founders & healthcare research teams the main success factors of pitching to Chinese investors and industry partners. Key sessions on developing a market entry strategy, successful partnering approaches, regulatory pathways, distribution and marketing, risks/pitfalls will all be covered (see program below)

09:05-09:15 Welcome speeches
Manyi Cristofoli, Director of Global Innovation, Queen Mary Innovation
Dr. Jerry Wu, Head of Investment, TusPark UK
Rob Scott, Managing Director, British China Technology Incubator
  
09:15-09:45  China Market; Overview of Healthcare/MedTech Sector
Dr Jiansheng Du, Deputy Head, Life Sciences Organization, Lead for China/Asia Pacific Investment, Department for International Trade (TBC)

09:45-10:15 IP Considerations & Planning for China
Hsu Min Ching, Partner  - HGF Limited

10.15-10.30 Regulatory Issues for Biotech/Medtech in China
David Madge, Vice President, Research Services, Wuxi AppTec (TBC)

10:30-10:45 Tea Break  
 
10:45-11:15  Partnerships, Contracts & Due Diligence in China
Mark Schaub | International Partner - Corporate/M&A
King & Wood Mallesons

11:15-11:45  How to attract Investment from China
Dr Jerry Wu, Head of Investment, TusPark UK

 
11.45-11.55 China British Business Council Expanding your network in China

11.55 – 12:15  Case Study

12:15-12:25  Wrap Up
Rob Scott, Managing Director,
British China Technology Incubator

If you are interested in this event, please confirm your attendance by emailing Phoebe Wang, Partnership and Communication Manager, Global Innovation Partner, QM Innovation on qiong.wang@qmul.ac.uk